… conditions such as genital warts in women is a global concern. Genital warts are a clinical
… The psychological stress of having genital warts is often greater than the morbidity of the …

Genital warts are a clinical manifestation of HPV types 6 and 11, and are estimated to affect
1% of sexuallyactive adults aged between 15 and 49. HPV leading to a broad spectrum of …

… An obstetric study that evaluated the use of 85% TCA in 50 female subjects with external
genital warts showed that all subjects were cleared of all lesions after a treatment period that …

… cumulative genital wart … female students 18–20 years of age recruited between July 1990
and September 1997, the 36-month cumulative incidence of clinically ascertained genital warts …

… wart clearance. Evidence suggests that T cells in male and the female genital epithelium
secrete protective antibodies against many HPV infections, the significance of this is unclear. …

… or Italian using the following search terms: (genital warts OR genital wart OR anogenital
warts OR anogenital wart OR condyloma* OR genital verruca*) AND (prevalence OR incidence …

… External genital warts (EGWs) are visible warts that occur in the perigenital and perianal
regions. They are due primarily to non-oncogenic human papillomavirus (HPV) types, usually …

… Genital warts caused by human … warts; some evidence exists that treatment reduces
infectivity, but there is no evidence that treatment reduces the incidence of cervical and genital …

… is a chemodestructive agent that causes chemical coagulation of genital warts. An 80–90%
solution of TCA is applied directly to the genital wart in the clinic or the physician's office. This …

Genital warts are an epidermal manifestation attributed to the epidermotropic human
papillomavirus (HPV). Over 100 types of double-stranded HPV have been isolated and completely …